• About
• Links
• Contact
• Sitemap

Nuclear Cardiology Markets

The purpose of this report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to diagnose and monitor heart diseases.

This study also discusses key products in nuclear cardiology and examines the trends that are stimulating this market. It includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth.

The main objectives of this analysis are to:

• Identify viable technology drivers through a comprehensive look at platform technologies for nuclear cardiology testing
• Obtain a complete understanding of the individual nuclear cardiology testing platforms from their basic principles to their clinical applications
• Discover feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas
• Focus on global industry developments through an in-depth analysis of the major world markets for nuclear cardiology technology, including growth forecasts

Present market figures related to the current value of nuclear cardiology, market projections, market share, key players, and sector growth rates. An analysis of the nuclear cardiology market must include several key areas of related activity.  The most important segments discussed in this report include:

• Hardware (e.g., nuclear cardiology instrumentation)
• Software (e.g., nuclear cardiology image processing, PACS)
• Radiopharmaceuticals and pharmaceuticals
• Ancillary products
• Service and support.

Table of Contents

• 1.Overview5
  • 1.1Objectives5
  • 1.2Scope6
  • 1.3Methodology6
  • 1.4Executive Summary6
  
  
• 2.Medical Imaging Market Analysis10
  • 2.1Medical Imaging Industry Market Size10
  • 2.2Medical Imaging Infrastructure11
    • 2.2.1Total Healthcare Expenditures and Demographics11
    • 2.2.2Number of Hospitals12
    • 2.2.3Number of Radiologists13
    • 2.2.4Radiology Services14
    • 2.2.5Medical Imaging Companies16
    • 2.2.6Market Drivers16
      • 2.2.6.1Product Enhancements17
      • 2.2.6.2Contrast Agents Development17
      • 2.2.6.3Innovation17
    • 2.2.7Market Restraints18
    • 2.2.8Market Segments for Medical Imaging18
      • 2.2.8.1Discovery18
      • 2.2.8.2Clinical Applications19
      • 2.2.8.3Clinical Trials19
      • 2.2.8.4Outpatient Facilities19
      • 2.2.8.5Technology Advances in Diagnostic Imaging Modalities19
      • 2.2.8.6Safety and Ergonomics Concerns19
      • 2.2.8.7Volumetric Imaging20
      • 2.2.8.8Digital Radiography (DR)20
      • 2.2.8.9Contrast Media21
      
      
• 3.Nuclear Medicine and Nuclear Cardiology Market29
  • 3.1Medical Imaging Industry Forecasts29
  • 3.2Hardware Companies (Nuclear Medicine Instrumentation)30
  • 3.3Software Companies (Image Processing and PACS)30
  • 3.4Radiopharmaceuticals and Pharmaceuticals Companies31
  • 3.5Ancillary Products Companies31
  • 3.6Service and Support Companies31
  • 3.7Nuclear Cardiology Market31
  • 3.8Hardware (PET, SPECT and Hybrids)33
    • 3.8.1Scanner Investment: Not Just a Cardiology Market33
      • 3.8.1.1Impact of Alzheimer\'s Reimbursement34
    • 3.8.2Sales Trends for PET Scanners34
    • 3.8.3Market Consolidation in the U.S.34
    • 3.8.4Learning Curve Impact for PET35
    • 3.8.5Hardware Market Trends35
  • 3.9Software (PACS and RIS)36
  • 3.10Radiopharmaceuticals37
    • 3.10.1Diagnostic Radiopharmaceuticals37
    • 3.10.2Therapeutic Radiopharmaceuticals37
    
    
• 4.Products Analysis38
  • 4.1Nuclear Medicine Instrumentation38
    • 4.1.1PET Scan38
    • 4.1.2SPECT Scan39
      • 4.1.2.1Heart Imaging41
    • 4.1.3PET Versus SPECT42
    • 4.1.4Hybrid Technology42
  • 4.2Image Processing: PACS46
    • 4.2.1PACS and Nuclear Medicine46
    • 4.2.2Difficulties in Making PACS Work with Nuclear Medicine46
      • 4.2.1.23-D and Quantitative Analysis47
      • 4.2.1.5Small Market Opportunities47
  • 4.3Radiopharmaceuticals and Pharmaceuticals47
    • 4.3.1Introduction47
    • 4.3.2Background48
    • 4.3.3Areas of Current Interest49
    
    
• 5.Regulations, Reimbursements and Other Issues50
  • 5.1Food and Drug Administration (FDA)50
    • 5.1.1FDA Guidance50
    • 5.1.2FDA Nuclear Medicine Coalition50
  • 5.2U.S. Nuclear Regulatory Commission (NRC)50
    • 5.2.1What NRC Regulates50
    • 5.2.2How NRC Regulates51
    • 5.2.3Related Information51
  • 5.3Memorandum of Understanding between NRC and FDA51
    • 5.3.1Authorities and Regulatory Programs51
  • 5.4Current NRC Issues and Actions54
    • 5.4.1Meetings54
    • 5.4.2Program and Policy Issues54
    • 5.4.3Recently Issued Significant Enforcement Actions55
      • 5.4.3.1Stark II Regulations55
      • 5.4.3.2Recent Impact of Stark II Regulations56
      • 5.4.3.3Reimbursement56
      
      
• 6.Business Affairs (Mergers, Acquisitions and Partnerships)57
  • 6.1Recent Corporate Partnerships and Mergers57
  • 6.2Recent Industry Activity57
  • 6.3Product Launches and Developments58
  
  
• 7.Technology Trends60
  • 7.1Hardware (Nuclear Medicine Instrumentation)60
  • 7.2Software (PACS)63
    • 7.2.1Problems Interfacing PACS and NM64
    • 7.2.2SNM and IHE64
    • 7.2.3IHE Nuclear Medicine Profile64
    • 7.2.4What Next?65
    • 7.2.5Optimal Patient Care66
    • 7.2.6Four Steps to Standards Adoption66
    • 7.2.7Technical Framework: Business with Technology67
    • 7.2.8Leading by Example68
    • 7.2.9IHE and Electronic Health Record (EHR)68
  • 7.3Radiopharmaceuticals and Pharmaceuticals68
    • 7.3.1Market Share69
    • 7.3.2Contrast Media Market Drivers70
    • 7.3.3Contrast Media Market Sector Overview70
    • 7.3.4Contrast Media Market Analysis71
    • 7.3.5Growth Prospects for Contrast Media71
  • 7.4Market Sector Analysis71
  • 7.5Leading Companies in General Medical Imaging73
  
  
• 8.Company Profiles74
  • 8.1Hardware (Nuclear Medicine Instrumentation)74
    • 8.1.1AccuSync Medical Research74
    • 8.1.2Bristol-Myers Squibb (Medical Imaging)74
    • 8.1.3Capintec75
    • 8.1.4CardiArc75
    • 8.1.5Cardinal Health (Cardiology Solutions)75
    • 8.1.6Digirad76
    • 8.1.7GE Healthcare76
    • 8.1.8GVI Medical Devices77
    • 8.1.9Hitachi Medical Systems America78
    • 8.1.10IS2 Medical Systems79
    • 8.1.11Mediso79
    • 8.1.12Philips Medical80
    • 8.1.13Positron81
    • 8.1.14Siemens Medical81
    • 8.1.15Spectrum Dynamics82
  • 8.2Software (Image Processing and PACS)83
    • 8.2.1Heartlab83
    • 8.2.2Hermes Medical Solutions84
    • 8.2.3INVIA84
    • 8.2.4McKesson85
    • 8.2.5MedImage85
    • 8.2.6MIMvista85
    • 8.2.7Numa86
    • 8.2.8ProSolv Cardiovascular86
    • 8.2.9Scientific Imaging86
    • 8.2.10Segami Corporation86
    • 8.2.11Syntermed86
    • 8.2.12Thinking Systems Corporation87
    • 8.2.13UltraSPECT87
    • 8.2.14Witt Biomedical Corporation87
  • 8.3Radiopharmaceuticals and Pharmaceuticals87
    • 8.3.1Astellas Pharma U.S.87
    • 8.3.2Bracco Diagnostics88
    • 8.3.3Isotope Products Laboratories88
    • 8.3.4Izotop: Institute of Isotopes89
    • 8.3.5Mallinckrodt89
    • 8.3.6Merck89
    • 8.3.7NuView Radiopharmaceuticals91
    • 8.3.8Pfizer91
    • 8.3.9Tyco Healthcare91
  • 8.4Ancillary Products92
    • 8.4.1CNMTStore.com92
    • 8.4.2Data Spectrum Corporation92
    • 8.4.3Daxor Corporation93
    • 8.4.4Ivy Biomedical Systems93
    • 8.4.5MarCal Medical93
  • 8.5Service and Support93
    • 8.5.1BC Technical93
    • 8.5.2Diagnostix Plus94
    • 8.5.3MedAxiom94
    • 8.5.4MediNuclear Corporation (MNC)94
    • 8.5.5MEDX94
    • 8.5.6Pinestar Technology95
    • 8.5.7Technology Imaging Services95
  • 8.6Other Business Opportunities95
  
  
• 9.Other Elements of Nuclear Medicine Industry96
  • 9.1Nuclear Medicine: Guidelines, Certification and Societies96
    • 9.1.1American College of Radiology (ACR)96
    • 9.1.2American Society of Nuclear Cardiology (ASNC)96
    • 9.1.3Associates in Medical Physics (AMP)96
    • 9.1.4Certification Board of Nuclear Cardiology (CBNC)96
    • 9.1.5ICANL97
    • 9.1.6IHE97
    • 9.1.7ISO97
    • 9.1.8MedPage Today97
    • 9.1.9Nuclear Medicine Technology Certification Board (NMTCB)97
    • 9.1.10Society of Cardiovascular Computed Tomography (SCCT)98
    • 9.1.11Society of Nuclear Medicine (SNM)98
  • 9.2Nuclear Medicine: Publications98
    • 9.2.1Elsevier98
    • 9.2.2HRA Research99
    • 9.2.3Lippincott Williams & Wilkins99
    
    
    

INDEX OF FIGURES

Figure 3.1: U.S. Nuclear Imaging Procedures32

Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-200632

Figure 4.1: Nuclear Imaging38

Figure 4.2: PET Scan39

Figure 4.3: SPECT Scan40

Figure 4.4: PET-CT Scan43

Figure 4.5: SPECT-CT Scan45

Figure 7.1: IHE Technical Framework66

Figure 7.2: IHE Framework Organization67

Figure 7.3: IHE Actors and Transactions68

INDEX OF TABLES

Table 2.1: U.S. Medical Imaging Market Size, 2001-201010

Table 2.2: Global Medical Imaging Market Size, 2001-201010

Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-201011

Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products11

Table 2.5: Millions of Americans Over 65 Years of Age, 2000-205012

Table 2.6: Hospital Survey12

Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-200415

Table 2.8: Worldwide Market Share of Medical Imaging Companies16

Table 2.9: Worldwide Imaging Procedures, 2001 to 201022

Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities27

Table 7.1: Market Share of Contrast Media Players69

Table 7.2: Contrast Media Market Growth, 2003-201070

Table 7.3: Worldwide Imaging Procedures, 2001-201072

Table 8.1: Astellas Alliances88

Other users found this report page using the following search terms: cardiology diagnostics Nuclear Medicine imaging pet spect nuclear cardiology medicine market procedure software medical hardware medicne growth

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.